Versant Vantage II, 10% Owner: Lenz Therapeutics LENZ Sell · Filed 25/09/22

Trade details

Type: Insider sale
Amount: $2,057,831.61
Shares · price: 49,479 sh · $41.59 a share
Held after: 1,224,718 sh
Stock: Lenz Therapeutics LENZ
Person: Versant Vantage II10% Owner
Trade date: 25/09/18
Filed: 25/09/22
Days to filing: 4 days

Sold 3.9% of holdings

Share of holding sold: 3.9%

Lenz Therapeutics trades, last 26 weeks

What else happened in Lenz Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/19~25/10/18

Versant Vantage II's recent trades

Versant Vantage II10% Owner
SellLenz Therapeutics
Sell
Lenz Therapeutics
LENZ
$3.9M
83,066 sh
$3.9M
Filed 25/10/02
Traded 25/09/30
Versant Vantage II10% Owner
SellLenz Therapeutics
Sell
Lenz Therapeutics
LENZ
$2.7M
57,502 sh
$2.7M
Filed 25/10/02
Traded 25/09/30
Versant Vantage II10% Owner
SellLenz Therapeutics
Sell
Lenz Therapeutics
LENZ
$2.3M
49,701 sh
$2.3M
Filed 25/10/02
Traded 25/09/30
Versant Vantage II10% Owner
SellLenz Therapeutics
Sell
Lenz Therapeutics
LENZ
$1.6M
34,405 sh
$1.6M
Filed 25/10/02
Traded 25/09/30
Versant Vantage II10% Owner
SellLenz Therapeutics
Sell
Lenz Therapeutics
LENZ
$5,782
123 sh
$5,782
Filed 25/10/02
Traded 25/09/30

Versant Vantage II, 10% Owner — sold $2.1M of Lenz Therapeutics LENZ · 3.9% of holdings | Whalegun